Cite

    Yopp, A. et al. (n.d.). Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment. Journal for immunotherapy of cancer. p. . [Online].